4WEALTH Advisors Inc. Has $411,000 Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

4WEALTH Advisors Inc. trimmed its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 49.0% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 829 shares of the medical equipment provider's stock after selling 795 shares during the quarter. 4WEALTH Advisors Inc.'s holdings in Intuitive Surgical were worth $411,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Chilton Capital Management LLC lifted its position in shares of Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock worth $25,000 after purchasing an additional 43 shares in the last quarter. Parvin Asset Management LLC purchased a new stake in shares of Intuitive Surgical in the fourth quarter worth approximately $26,000. Global Financial Private Client LLC lifted its position in shares of Intuitive Surgical by 253.3% in the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock worth $26,000 after purchasing an additional 38 shares in the last quarter. Elite Financial Inc. purchased a new stake in shares of Intuitive Surgical in the first quarter worth approximately $26,000. Finally, Hurley Capital LLC purchased a new stake in shares of Intuitive Surgical in the fourth quarter worth approximately $28,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research firms have recently issued reports on ISRG. Robert W. Baird reduced their price target on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. Truist Financial increased their price target on shares of Intuitive Surgical from $590.00 to $600.00 and gave the stock a "buy" rating in a research report on Wednesday. BTIG Research raised their price objective on shares of Intuitive Surgical from $566.00 to $571.00 and gave the company a "buy" rating in a research report on Wednesday. Citigroup reaffirmed a "buy" rating and set a $650.00 price objective (up previously from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. Finally, Evercore ISI raised their price objective on shares of Intuitive Surgical from $470.00 to $550.00 and gave the company an "in-line" rating in a research report on Tuesday, July 8th. One analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have given a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $592.05.

Intuitive Surgical Stock Down 2.5%

ISRG stock traded down $12.46 during midday trading on Thursday, hitting $489.49. 993,419 shares of the company traded hands, compared to its average volume of 1,982,586. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00. The business has a 50 day simple moving average of $532.65 and a 200-day simple moving average of $535.75. The stock has a market capitalization of $175.44 billion, a price-to-earnings ratio of 68.27, a price-to-earnings-growth ratio of 5.42 and a beta of 1.64.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.89% and a net margin of 28.51%. The company had revenue of $2.44 billion for the quarter, compared to the consensus estimate of $2.35 billion. During the same quarter last year, the company posted $1.78 earnings per share. The company's revenue for the quarter was up 21.4% compared to the same quarter last year. Equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Activity at Intuitive Surgical

In other news, EVP Robert Desantis sold 188 shares of the firm's stock in a transaction on Monday, April 28th. The shares were sold at an average price of $515.91, for a total value of $96,991.08. Following the sale, the executive vice president owned 5,224 shares in the company, valued at approximately $2,695,113.84. This trade represents a 3.47% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Jami K. Nachtsheim sold 2,400 shares of the firm's stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the completion of the sale, the director owned 6,371 shares in the company, valued at approximately $3,312,920. The trade was a 27.36% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 4,998 shares of company stock worth $2,611,577. Insiders own 0.70% of the company's stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.